Breaking News Instant updates and real-time market news.

2022-03-15 08:43:58 ACTG Acacia Research $3.35 / -0.17 (-4.83%) , SVAC Starboard Value Acquisition $9.54 / + (+0.00%) 08:43 03/15/22 03/15 08:43 03/15/22 08:43	Acacia Research appoints Martin McNulty as COO, Wesley Golby as CIO Acacia Research (ACTG) announced that it has appointed Martin McNulty, Jr. as COO and Head of M&A and that Wesley Golby has been promoted to CIO. The appointments are effective immediately. McNulty most recently served as the Chief Executive Officer and a member of the board of directors at Starboard Value Acquisition Corp. (SVAC). Golby has served as Director of Research at Acacia since August 2020. ACTG Acacia Research $3.35 / -0.17 (-4.83%) SVAC Starboard Value Acquisition $9.54 / + (+0.00%)

2022-03-15 08:43:58

ACTG

Acacia Research

$3.35 / -0.17 (-4.83%)

, SVAC

Starboard Value Acquisition

$9.54 / + (+0.00%)

08:43

03/15/22

03/15

08:43

03/15/22

08:43

Acacia Research appoints Martin McNulty as COO, Wesley Golby as CIO

Acacia Research (ACTG) announced that it has appointed Martin McNulty, Jr. as COO and Head of M&A and that Wesley Golby has been promoted to CIO. The appointments are effective immediately. McNulty most recently served as the Chief Executive Officer and a member of the board of directors at Starboard Value Acquisition Corp. (SVAC). Golby has served as Director of Research at Acacia since August 2020.

ACTG

Acacia Research

$3.35 / -0.17 (-4.83%)

SVAC

Starboard Value Acquisition

$9.54 / + (+0.00%)

OTHER BREAKING NEWS FROM THE FLY

Earnings	Central Garden & Pet reports Q1 EPS (16c), consensus (17c) » 16:04 01/31/23 01/31 16:04 01/31/23 16:04 CENTA Central Garden & Pet $39.56 / +1.11 (+2.89%) Reports Q1 revenue $628M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events CENTA Central Garden & Pet $39.56 / +1.11 (+2.89%) 01/13/23 JPMorgan Central Garden & Pet price target lowered to $39 from $40 at JPMorgan 10/13/22 JPMorgan Central Garden & Pet price target lowered to $37 from $45 at JPMorgan 08/25/22 CJS Securities Central Garden & Pet initiated with an Outperform at CJS Securities 08/08/22 Truist Central Garden & Pet price target lowered to $60 from $65 at Truist CENTA Central Garden & Pet $39.56 / +1.11 (+2.89%) 11/21/22 Central Garden & Pet sees FY23 EPS $2.60-$2.80, consensus $2.93 11/21/22 Central Garden & Pet reports Q4 EPS (4c), consensus 1c 08/03/22 Central Garden & Pet sees FY22 EPS at or above prior year 08/03/22 Central Garden & Pet reports Q3 EPS $1.39, consensus $1.27 16:30 Today Central Garden & Pet - CENTA 02/07/23 Central Garden & Pet Company Class A
Hot Stocks	Amgen sees FY23 CapEx about $925M » 16:03 01/31/23 01/31 16:03 01/31/23 16:03 AMGN Amgen $252.45 / +0.88 (+0.35%) FY23 share repurchases… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMGN Amgen $252.45 / +0.88 (+0.35%) 06:18 Today Amgen announces Humira biosimilar now available in the U.S. 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial AMGN Amgen $252.45 / +0.88 (+0.35%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird AMGN Amgen $252.45 / +0.88 (+0.35%) 16:02 Today Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33 16:02 Today Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33 16:01 Today Amgen reports Q4 adjusted EPS $4.09, consensus $4.09 13:20 Today Notable companies reporting after market close AMGN Amgen $252.45 / +0.88 (+0.35%) 06:26 Today AbbVie's Humira drug faces competition in the U.S., FT reports 01/30/23 Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports 12/11/22 Amgen nears deal to acquire Horizon Therapeutics, WSJ reports AMGN Amgen $252.45 / +0.88 (+0.35%) 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 03/09/23 Biopharma/Biotech 02/24/23 Annual Meeting of AAAAI 2023 16:30 Today Amgen - AMGN AMGN Amgen $252.45 / +0.88 (+0.35%) 14:04 Today Amgen options imply 3.2% move in share price post-earnings 10/11/22 Early notable gainers among liquid option names on October 11th
Earnings	Electronic Arts sees Q4 EPS 5c-20c, consensus $2.22 » 16:03 01/31/23 01/31 16:03 01/31/23 16:03 EA Electronic Arts $128.68 / -0.35 (-0.27%) Sees Q4 net bookings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EA Electronic Arts $128.68 / -0.35 (-0.27%) 01/19/23 Sony announces additional games coming to PlayStation VR2 01/17/23 U.S. video game consumer spending rose 2% y/y in December, says NPD 01/17/23 'Call of Duty: Modern Warfare 2' top game seller in U.S. in December, says NPD 11/21/22 Electronic Arts CEO Wilson sells 10,000 common shares EA Electronic Arts $128.68 / -0.35 (-0.27%) 01/27/23 Wedbush Electronic Arts initiated with an Outperform at Wedbush 01/27/23 Credit Suisse Electronic Arts price target raised to $154 from $143 at Credit Suisse 01/25/23 Barclays Electronic Arts price target raised to $132 from $130 at Barclays 01/17/23 Benchmark Electronic Arts price target lowered to $150 from $188 at Benchmark EA Electronic Arts $128.68 / -0.35 (-0.27%) 16:02 Today Electronic Arts reports Q3 EPS 73, consensus $3.05 13:20 Today Notable companies reporting after market close 11/01/22 Electronic Arts raises FY23 EPS view to $3.11-$3.34 from $2.79-$2.87 11/01/22 Electronic Arts sees Q3 EPS 43c-59c, consensus $3.01 EA Electronic Arts $128.68 / -0.35 (-0.27%) 01/30/23 EA's 'Dead Space' top-selling physical game in U.K., GI.biz says 01/23/23 Nintendo's new 'Fire Emblem' top-selling physical game in U.K., GI.biz says 01/18/23 Video game sales fell 13% y/y in Europe in December, GI.biz says 01/11/23 Amazon Game Studios loses another key executive amid cutbacks, Bloomberg says EA Electronic Arts $128.68 / -0.35 (-0.27%) 13:51 Today What You Missed This Week in Video Games 01/24/23 What You Missed This Week in Video Games 01/17/23 What You Missed This Week in Video Games 01/10/23 What You Missed This Week in Video Games 17:00 Today Electronic Arts - EA EA Electronic Arts $128.68 / -0.35 (-0.27%) 14:34 Today Electronic Arts options imply 4.3% move in share price post-earnings 10/05/22 Electronic Arts put volume heavy and directionally bearish 10/03/22 Electronic Arts Inc. call volume above normal and directionally bullish 08/26/22 Early notable gainers among liquid option names on August 26th
Earnings	Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33 » 16:02 01/31/23 01/31 16:02 01/31/23 16:02 AMGN Amgen $252.39 / +0.82 (+0.33%) Sees FY23 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMGN Amgen $252.39 / +0.82 (+0.33%) 06:18 Today Amgen announces Humira biosimilar now available in the U.S. 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial AMGN Amgen $252.39 / +0.82 (+0.33%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird AMGN Amgen $252.39 / +0.82 (+0.33%) 16:02 Today Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33 16:01 Today Amgen reports Q4 adjusted EPS $4.09, consensus $4.09 13:20 Today Notable companies reporting after market close 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 AMGN Amgen $252.39 / +0.82 (+0.33%) 06:26 Today AbbVie's Humira drug faces competition in the U.S., FT reports 01/30/23 Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports 12/11/22 Amgen nears deal to acquire Horizon Therapeutics, WSJ reports AMGN Amgen $252.39 / +0.82 (+0.33%) 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 03/09/23 Biopharma/Biotech 02/24/23 Annual Meeting of AAAAI 2023 16:30 Today Amgen - AMGN AMGN Amgen $252.39 / +0.82 (+0.33%) 14:04 Today Amgen options imply 3.2% move in share price post-earnings 10/11/22 Early notable gainers among liquid option names on October 11th
Earnings	Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33 » 16:02 01/31/23 01/31 16:02 01/31/23 16:02 AMGN Amgen $252.39 / +0.82 (+0.33%) Sees FY23 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMGN Amgen $252.39 / +0.82 (+0.33%) 06:18 Today Amgen announces Humira biosimilar now available in the U.S. 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial AMGN Amgen $252.39 / +0.82 (+0.33%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird AMGN Amgen $252.39 / +0.82 (+0.33%) 16:01 Today Amgen reports Q4 adjusted EPS $4.09, consensus $4.09 13:20 Today Notable companies reporting after market close 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70, consensus $4.44 AMGN Amgen $252.39 / +0.82 (+0.33%) 06:26 Today AbbVie's Humira drug faces competition in the U.S., FT reports 01/30/23 Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports 12/11/22 Amgen nears deal to acquire Horizon Therapeutics, WSJ reports AMGN Amgen $252.39 / +0.82 (+0.33%) 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 03/09/23 Biopharma/Biotech 02/24/23 Annual Meeting of AAAAI 2023 16:30 Today Amgen - AMGN AMGN Amgen $252.39 / +0.82 (+0.33%) 14:04 Today Amgen options imply 3.2% move in share price post-earnings 10/11/22 Early notable gainers among liquid option names on October 11th
Earnings	Electronic Arts reports Q3 EPS 73, consensus $3.05 » 16:02 01/31/23 01/31 16:02 01/31/23 16:02 EA Electronic Arts $128.68 / -0.35 (-0.27%) Reports Q3 net bookings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EA Electronic Arts $128.68 / -0.35 (-0.27%) 01/19/23 Sony announces additional games coming to PlayStation VR2 01/17/23 U.S. video game consumer spending rose 2% y/y in December, says NPD 01/17/23 'Call of Duty: Modern Warfare 2' top game seller in U.S. in December, says NPD 11/21/22 Electronic Arts CEO Wilson sells 10,000 common shares EA Electronic Arts $128.68 / -0.35 (-0.27%) 01/27/23 Wedbush Electronic Arts initiated with an Outperform at Wedbush 01/27/23 Credit Suisse Electronic Arts price target raised to $154 from $143 at Credit Suisse 01/25/23 Barclays Electronic Arts price target raised to $132 from $130 at Barclays 01/17/23 Benchmark Electronic Arts price target lowered to $150 from $188 at Benchmark EA Electronic Arts $128.68 / -0.35 (-0.27%) 13:20 Today Notable companies reporting after market close 11/01/22 Electronic Arts raises FY23 EPS view to $3.11-$3.34 from $2.79-$2.87 11/01/22 Electronic Arts sees Q3 EPS 43c-59c, consensus $3.01 11/01/22 Electronic Arts reports Q2 EPS $1.07, consensus $1.37 EA Electronic Arts $128.68 / -0.35 (-0.27%) 01/30/23 EA's 'Dead Space' top-selling physical game in U.K., GI.biz says 01/23/23 Nintendo's new 'Fire Emblem' top-selling physical game in U.K., GI.biz says 01/18/23 Video game sales fell 13% y/y in Europe in December, GI.biz says 01/11/23 Amazon Game Studios loses another key executive amid cutbacks, Bloomberg says EA Electronic Arts $128.68 / -0.35 (-0.27%) 13:51 Today What You Missed This Week in Video Games 01/24/23 What You Missed This Week in Video Games 01/17/23 What You Missed This Week in Video Games 01/10/23 What You Missed This Week in Video Games 17:00 Today Electronic Arts - EA EA Electronic Arts $128.68 / -0.35 (-0.27%) 14:34 Today Electronic Arts options imply 4.3% move in share price post-earnings 10/05/22 Electronic Arts put volume heavy and directionally bearish 10/03/22 Electronic Arts Inc. call volume above normal and directionally bullish 08/26/22 Early notable gainers among liquid option names on August 26th
General news	December farm prices up 22.0% vs. last year 16:01 01/31/23 01/31 16:01 01/31/23 16:01 $ECON Economic Data / + ShowHide Related Items >><< Street Research Periodicals On The Fly $ECON Economic Data / + $ECON Economic Data / + 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says 01/22/23 Fed sets course for milder interest-rate rise next month, WSJ says 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says $ECON Economic Data / + 01/24/23 What You Missed On Wall Street On Tuesday 01/18/23 What You Missed On Wall Street On Wednesday 12/15/22 What You Missed On Wall Street On Thursday 12/15/22 What You Missed On Wall Street This Morning
General news	December farm prices up 3.1% vs. last month 16:01 01/31/23 01/31 16:01 01/31/23 16:01 $ECON Economic Data / + ShowHide Related Items >><< Street Research Periodicals On The Fly $ECON Economic Data / + $ECON Economic Data / + 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says 01/22/23 Fed sets course for milder interest-rate rise next month, WSJ says 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says $ECON Economic Data / + 01/24/23 What You Missed On Wall Street On Tuesday 01/18/23 What You Missed On Wall Street On Wednesday 12/15/22 What You Missed On Wall Street On Thursday 12/15/22 What You Missed On Wall Street This Morning
Earnings	Amgen reports Q4 adjusted EPS $4.09, consensus $4.09 » 16:01 01/31/23 01/31 16:01 01/31/23 16:01 AMGN Amgen $252.23 / +0.66 (+0.26%) Reports Q4 revenue $6.8B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMGN Amgen $252.23 / +0.66 (+0.26%) 06:18 Today Amgen announces Humira biosimilar now available in the U.S. 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial AMGN Amgen $252.23 / +0.66 (+0.26%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird AMGN Amgen $252.23 / +0.66 (+0.26%) 13:20 Today Notable companies reporting after market close 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70, consensus $4.44 11/03/22 Notable companies reporting after market close AMGN Amgen $252.23 / +0.66 (+0.26%) 06:26 Today AbbVie's Humira drug faces competition in the U.S., FT reports 01/30/23 Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports 12/11/22 Amgen nears deal to acquire Horizon Therapeutics, WSJ reports AMGN Amgen $252.23 / +0.66 (+0.26%) 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 03/09/23 Biopharma/Biotech 02/24/23 Annual Meeting of AAAAI 2023 16:30 Today Amgen - AMGN AMGN Amgen $252.23 / +0.66 (+0.26%) 14:04 Today Amgen options imply 3.2% move in share price post-earnings 10/11/22 Early notable gainers among liquid option names on October 11th
Hot Stocks	Kushner says $18.50 offer for Veris Residential remains outstanding » 16:01 01/31/23 01/31 16:01 01/31/23 16:01 VRE Veris Residential $17.16 / +0.26 (+1.54%) Kushner, which identifies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events VRE Veris Residential $17.16 / +0.26 (+1.54%) 01/19/23 Veris Residential shareholder Kushner responds to Veris Board statement 01/18/23 Veris Residential falls 9% to $14.88 after Kushner Co. pulls out of deal talks 01/18/23 Veris Residential issues statement on strategic alternatives 01/18/23 Veris Residential forms strategic partnership with the MIT VRE Veris Residential $17.16 / +0.26 (+1.54%) 01/19/23 BTIG BTIG continues to see value in Veris Residential 12/13/22 BTIG Veris Residential price target lowered to $22 from $26 at BTIG 11/14/22 BofA Veris Residential upgraded to Neutral at BofA in residential REIT repositioning 11/14/22 BofA Veris Residential upgraded to Neutral from Underperform at BofA VRE Veris Residential $17.16 / +0.26 (+1.54%) 08/03/22 Veris Residential reports Q2 core FFO 15c, consensus 12c VRE Veris Residential $17.16 / +0.26 (+1.54%) 11/22/22 Fortress agrees to finance Kushner bid to acquire Veris Residential, WSJ says VRE Veris Residential $17.16 / +0.26 (+1.54%) 10/21/22 What You Missed On Wall Street On Friday 10/21/22 What You Missed On Wall Street This Morning 10/21/22 Fly Intel: Pre-market Movers 02/22/23 Veris Residential - VRE

Hot Stocks	FFBW Inc trading halted, news pending 16:01 01/31/23 01/31 16:01 01/31/23 16:01
Conference/Events	JPMorgan Mexican strategist to hold analyst/industry conference call » 15:59 01/31/23 01/31 15:59 01/31/23 15:59 Mexico Equity Strategist… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Target says Omaha West store closed until further notice following incident » 15:57 01/31/23 01/31 15:57 01/31/23 15:57 TGT Target $171.76 / +3.08 (+1.83%) Target issued the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TGT Target $171.76 / +3.08 (+1.83%) 01/09/23 Mattel's Fisher-Price re-announces recall of 4.7M Rock 'n Play Sleepers 12/22/22 Target recalls roughly 204,000 children's weighted blankets after two deaths 11/25/22 Target announces Cyber Monday sales event from Nov. 27-28 11/17/22 Target announces largest Black Friday week sale ever from Nov. 20-26 TGT Target $171.76 / +3.08 (+1.83%) 01/23/23 Oppenheimer Target initiated with an Outperform at Oppenheimer 01/04/23 Wells Fargo Wells Fargo downgrades Target to Equal Weight, lowers price target to $142 01/04/23 Wells Fargo Target downgraded to Equal Weight from Overweight at Wells Fargo 12/21/22 Gordon Haskett Gordon Haskett downgrades Target on 'meaningfully eroded' traffic TGT Target $171.76 / +3.08 (+1.83%) 11/16/22 Target on track to deliver total sales of well over $100B this year, says COO 11/16/22 Target reports Q3 adjusted EPS $1.54, consensus $2.13 11/15/22 Notable companies reporting before tomorrow's open 11/15/22 Notable companies reporting before tomorrow's open TGT Target $171.76 / +3.08 (+1.83%) 11/14/22 Walmart taking 'aggressive' stance with suppliers, WSJ reports 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says 09/03/22 Target's problems won't last forever, time to buy stock, Barron's says TGT Target $171.76 / +3.08 (+1.83%) 01/28/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations TGT Target $171.76 / +3.08 (+1.83%) 01/19/23 Target put volume heavy and directionally bearish 01/06/23 Early notable gainers among liquid option names on January 6th 01/06/23 Unusually active option classes on open January 6th 11/28/22 Early notable gainers among liquid option names on November 28th
Recommendations	Wolters Kluwer price target lowered to EUR 120 from EUR 125 at Barclays » 15:53 01/31/23 01/31 15:53 01/31/23 15:53 WTKWY Wolters Kluwer $108.24 / +0.805 (+0.75%) Barclays analyst Nick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research WTKWY Wolters Kluwer $108.24 / +0.805 (+0.75%) 01/09/23 Wolters Kluwer acquires NurseTim, terms not disclosed 12/30/22 Wolters Kluwer acquires Della AI, terms not disclosed 11/30/22 Wolters Kluwer completes divestment of legal information units in France, Spain 08/31/22 Wolters Kluwer completes capital reduction WTKWY Wolters Kluwer $108.24 / +0.805 (+0.75%) 01/18/23 Credit Suisse Wolters Kluwer price target lowered to EUR 115 from EUR 116 at Credit Suisse 12/16/22 Morgan Stanley Wolters Kluwer price target raised to EUR 129 from EUR 126 at Morgan Stanley 12/12/22 JPMorgan Wolters Kluwer price target lowered to EUR 108 from EUR 113 at JPMorgan 12/01/22 Exane BNP Paribas Wolters Kluwer downgraded to Underperform from Neutral at Exane BNP Paribas
Recommendations	Vivendi price target raised to EUR 12.50 from EUR 12.20 at Barclays » 15:53 01/31/23 01/31 15:53 01/31/23 15:53 VIVHY Vivendi $10.72 / -0.02 (-0.19%) Barclays analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research VIVHY Vivendi $10.72 / -0.02 (-0.19%) 01/20/23 Morgan Stanley Vivendi price target raised to EUR 13.60 from EUR 13.40 at Morgan Stanley 12/16/22 Morgan Stanley Vivendi price target raised to EUR 13.40 from EUR 12.30 at Morgan Stanley 12/12/22 JPMorgan Vivendi price target lowered to EUR 12.30 from EUR 13.40 at JPMorgan 10/24/22 AlphaValue/Baader Vivendi downgraded to Add from Buy at AlphaValue/Baader
Recommendations	Stroeer price target raised to EUR 54 from EUR 47.50 at Barclays » 15:53 01/31/23 01/31 15:53 01/31/23 15:53 SOTDY Stroeer $18.00 / + (+0.00%) Barclays analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SOTDY Stroeer $18.00 / + (+0.00%) 01/18/23 Exane BNP Paribas Stroeer downgraded to Underperform from Outperform at Exane BNP Paribas 12/02/22 JPMorgan Stroeer price target raised to EUR 46 from EUR 41 at JPMorgan 11/14/22 UBS Stroeer price target lowered to EUR 60 from EUR 62 at UBS 11/11/22 Barclays Stroeer price target lowered to EUR 47.50 from EUR 53 at Barclays
Recommendations	RTL Group price target raised to EUR 46 from EUR 39 at Barclays » 15:52 01/31/23 01/31 15:52 01/31/23 15:52 RGLXY RTL Group $4.55 / + (+0.00%) Barclays analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RGLXY RTL Group $4.55 / + (+0.00%) 01/18/23 Goldman Sachs RTL Group downgraded to Neutral from Buy at Goldman Sachs 09/16/22 Barclays RTL Group price target raised to EUR 42 from EUR 41.75 at Barclays 08/09/22 Barclays RTL Group price target lowered to EUR 41.75 from EUR 54 at Barclays 07/28/22 Deutsche Bank RTL Group price target lowered to EUR 47 from EUR 59 at Deutsche Bank
Recommendations	Publicis price target raised to EUR 68 from EUR 62.50 at Barclays » 15:51 01/31/23 01/31 15:51 01/31/23 15:51 PUBGY Publicis $17.60 / +0.11 (+0.63%) Barclays analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events PUBGY Publicis $17.60 / +0.11 (+0.63%) 10/18/22 Chicken Soup teams with Publicis' APX Content Ventures on new reality series PUBGY Publicis $17.60 / +0.11 (+0.63%) 01/06/23 UBS Publicis price target raised to EUR 71 from EUR 68 at UBS 12/16/22 Morgan Stanley Publicis price target raised to EUR 53 from EUR 50 at Morgan Stanley 12/12/22 JPMorgan Publicis price target raised to EUR 82 from EUR 75 at JPMorgan 11/04/22 Berenberg Publicis price target raised to EUR 70 from EUR 61 at Berenberg 02/02/23 Publicis - PUBGY
Hot Stocks	Cvent jumps 15% after WSJ says company exploring sale 15:51 01/31/23 01/31 15:51 01/31/23 15:51 CVT Cvent $6.74 / +0.16 (+2.43%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CVT Cvent $6.74 / +0.16 (+2.43%) 15:48 Today Dragoneer Growth Opportunities trading halted, volatility trading pause 11/09/22 Cvent, Zoom Video partner for hybrid events 10/19/22 American Express, Cvent team up on virtual payment capabilities CVT Cvent $6.74 / +0.16 (+2.43%) 09/23/22 Credit Suisse Cvent initiated with an Outperform at Credit Suisse 06/17/22 Morgan Stanley Cvent initiated with an Equal Weight at Morgan Stanley 05/10/22 Canaccord Cvent price target lowered to $8 from $11 at Canaccord 03/08/22 Colliers Cvent initiated with a Buy at Colliers CVT Cvent $6.74 / +0.16 (+2.43%) 11/03/22 Cvent raises FY22 revenue view to $628.9M-$629.9M from $624.9M-$628.4M 11/03/22 Cvent sees Q4 revenue $169.3M-$170.3M, consensus $169.29M 11/03/22 Cvent reports Q3 EPS (4c), consensus 4c 08/04/22 Cvent narrows FY22 revenue view to $624.9M-$628.4M, consensus $622.97M CVT Cvent $6.74 / +0.16 (+2.43%) 15:51 Today Cvent exploring sale, Blackstone among suitors, WSJ says 15:49 Today Cvent exploring sale, Blackstone among suitors, WSJ says CVT Cvent $6.74 / +0.16 (+2.43%) 11/09/22 #SocialStocks: Shares responds as Meta axes 13% of workforce
Recommendations	Prudential plc price target lowered to 1,518 GBp from 1,585 GBp at Barclays » 15:51 01/31/23 01/31 15:51 01/31/23 15:51 PUK Prudential plc $33.29 / +0.265 (+0.80%) Barclays analyst Larissa… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research PUK Prudential plc $33.29 / +0.265 (+0.80%) 10/10/22 Prudential plc, Google Cloud announce strategic partnership PUK Prudential plc $33.29 / +0.265 (+0.80%) 01/18/23 JPMorgan Prudential plc price target raised to 1,750 GBp from 1,500 GBp at JPMorgan 01/16/23 Goldman Sachs Prudential plc upgraded to Conviction Buy from Buy at Goldman Sachs 01/10/23 Deutsche Bank Prudential plc price target raised to 1,450 GBp from 1,400 GBp at Deutsche Bank 01/05/23 Exane BNP Paribas Prudential plc downgraded to Underperform from Neutral at Exane BNP Paribas

Recommendations	ProSiebenSat.1 Media price target raised to EUR 10 from EUR 8.50 at Barclays » 15:51 01/31/23 01/31 15:51 01/31/23 15:51 PBSFY ProSiebenSat.1 Media $2.55 / +0.01 (+0.39%) Barclays analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PBSFY ProSiebenSat.1 Media $2.55 / +0.01 (+0.39%) 01/17/23 UBS ProSiebenSat.1 Media price target raised to EUR 11 from EUR 8.80 at UBS 01/05/23 BofA ProSiebenSat.1 Media downgraded to Underperform from Neutral at BofA 12/16/22 Morgan Stanley ProSiebenSat.1 price target lowered to EUR 6 from EUR 6.20 at Morgan Stanley 12/12/22 JPMorgan ProSiebenSat.1 Media downgraded to Neutral from Overweight at JPMorgan
Periodicals	Cvent exploring sale, Blackstone among suitors, WSJ says » 15:51 01/31/23 01/31 15:51 01/31/23 15:51 CVT Cvent $6.74 / +0.16 (+2.43%) , BX Blackstone $95.32 / +0.43 (+0.45%) Cvent (CVT) is exploring… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CVT BX CVT Cvent $6.74 / +0.16 (+2.43%) 15:48 Today Dragoneer Growth Opportunities trading halted, volatility trading pause 11/09/22 Cvent, Zoom Video partner for hybrid events 10/19/22 American Express, Cvent team up on virtual payment capabilities BX Blackstone $95.32 / +0.43 (+0.45%) 01/11/23 COPT forms two data center JVs with Blackstone Real Estate 01/03/23 UC Investments to invest $4B in Blackstone Real Estate Income Trust 01/03/23 Targa to acquire Blackstone's 25% interest in Grand Prix for $1.05B 12/12/22 Thomson Reuters, Blackstone to sell shares of LSEG to Microsoft CVT BX CVT Cvent $6.74 / +0.16 (+2.43%) 09/23/22 Credit Suisse Cvent initiated with an Outperform at Credit Suisse 06/17/22 Morgan Stanley Cvent initiated with an Equal Weight at Morgan Stanley 05/10/22 Canaccord Cvent price target lowered to $8 from $11 at Canaccord 03/08/22 Colliers Cvent initiated with a Buy at Colliers BX Blackstone $95.32 / +0.43 (+0.45%) 01/27/23 BMO Capital Blackstone price target raised to $92 from $85 at BMO Capital 01/27/23 Barclays Blackstone price target raised to $100 from $86 at Barclays 01/24/23 JPMorgan TPG downgraded to Neutral from Overweight at JPMorgan 01/24/23 JPMorgan Blackstone upgraded to Overweight from Neutral at JPMorgan CVT BX CVT Cvent $6.74 / +0.16 (+2.43%) 11/03/22 Cvent raises FY22 revenue view to $628.9M-$629.9M from $624.9M-$628.4M 11/03/22 Cvent sees Q4 revenue $169.3M-$170.3M, consensus $169.29M 11/03/22 Cvent reports Q3 EPS (4c), consensus 4c 08/04/22 Cvent narrows FY22 revenue view to $624.9M-$628.4M, consensus $622.97M BX Blackstone $95.32 / +0.43 (+0.45%) 01/27/23 Blackstone reports Q4 distributable EPS $1.07 vs. $1.71 y/y 01/25/23 Notable companies reporting before tomorrow's open 01/25/23 UC Investments to invest additional $500M in BREIT common shares 01/25/23 Notable companies reporting before tomorrow's open CVT BX CVT Cvent $6.74 / +0.16 (+2.43%) 15:49 Today Cvent exploring sale, Blackstone among suitors, WSJ says BX Blackstone $95.32 / +0.43 (+0.45%) 15:49 Today Cvent exploring sale, Blackstone among suitors, WSJ says 01/30/23 Blackstone files eviction lawsuits against hundreds of tenants, FT reports 12/21/22 Justin Bieber nearing $200M deal to sell music rights, WSJ says 12/10/22 BREIT move to limit redemptions 'a wake-up' for investors, Barron's says CVT BX CVT Cvent $6.74 / +0.16 (+2.43%) 11/09/22 #SocialStocks: Shares responds as Meta axes 13% of workforce BX Blackstone $95.32 / +0.43 (+0.45%) 01/30/23 What You Missed On Wall Street This Morning 01/27/23 What You Missed On Wall Street On Friday 01/27/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BX BX Blackstone $95.32 / +0.43 (+0.45%) 12/02/22 Unusually active option classes on open December 2nd 12/02/22 Blackstone put buyer realizes 30% same-day gains 12/01/22 Blackstone put volume heavy and directionally bearish 12/01/22 Unusually active option classes on open December 1st
Options	Million dollar call Seller in Northern Oil and Gas » 15:50 01/31/23 01/31 15:50 01/31/23 15:50 NOG Northern Oil and Gas $33.25 / -0.21 (-0.63%) Million dollar call… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NOG Northern Oil and Gas $33.25 / -0.21 (-0.63%) 01/26/23 Northern Oil and Gas to replace South Jersey Industries in S&P 600 at open 2/2 11/10/22 Northern Oil and Gas increases borrowing base to $1.6B from $1.3B 11/03/22 Northern Oil and Gas raises quarterly cash dividend 20% to 30c per share 10/19/22 Northern Oil and Gas acquires properties in core of Midland Basin NOG Northern Oil and Gas $33.25 / -0.21 (-0.63%) 01/06/23 BofA Northern Oil upgraded to Buy on cash flow growth at BofA 01/06/23 BofA Northern Oil and Gas upgraded to Buy from Neutral at BofA 01/04/23 Raymond James Northern Oil and Gas price target lowered to $55 from $60 at Raymond James 11/25/22 Citi Northern Oil and Gas price target raised to $46 from $36 at Citi NOG Northern Oil and Gas $33.25 / -0.21 (-0.63%) 11/08/22 Northern Oil and Gas reports Q3 adjusted EPS $1.80, consensus $1.69 08/03/22 Northern Oil and Gas reports Q2 adjusted EPS $1.72, consensus $1.70 NOG Northern Oil and Gas $33.25 / -0.21 (-0.63%) 01/27/23 What You Missed On Wall Street On Friday 01/27/23 What You Missed On Wall Street This Morning 01/26/23 Fly Intel: After-Hours Movers 10/11/22 What You Missed On Wall Street This Morning 02/24/23 Northern Oil and Gas - NOG
Recommendations	ITV price target raised to 80 GBp from 70 GBp at Barclays » 15:50 01/31/23 01/31 15:50 01/31/23 15:50 ITVPY ITV $10.16 / -0.181 (-1.75%) Barclays analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ITVPY ITV $10.16 / -0.181 (-1.75%) 12/16/22 Morgan Stanley ITV price target lowered to 47 GBp from 54 GBp at Morgan Stanley 12/12/22 JPMorgan ITV price target lowered to 140 GBp from 160 GBp at JPMorgan 11/10/22 JPMorgan ITV price target lowered to 160 GBp from 170 GBp at JPMorgan 11/10/22 Societe Generale ITV price target lowered to 121 GBp from 126 GBp at Societe Generale
Recommendations	Haleon price target raised to 364 GBp from 360 GBp at Barclays » 15:49 01/31/23 01/31 15:49 01/31/23 15:49 HLN Haleon $8.09 / +0.09 (+1.13%) Barclays analyst Iain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly HLN Haleon $8.09 / +0.09 (+1.13%) 08/21/22 Fly Intel: Top five weekend stock stories 08/11/22 Haleon says it is not a party to any Zantac claims 08/11/22 GSK says no new 'material developments' related to Zantac litigation HLN Haleon $8.09 / +0.09 (+1.13%) 01/06/23 Morgan Stanley Haleon upgraded to Overweight from Equal Weight at Morgan Stanley 12/21/22 Barclays Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays 12/07/22 Barclays Haleon upgraded to Overweight from Equal Weight at Barclays 11/15/22 Morgan Stanley Haleon assumed with an Equal Weight at Morgan Stanley HLN Haleon $8.09 / +0.09 (+1.13%) 08/20/22 Buy Haleon on steady growth, planned dividend, Barron's says 08/17/22 Generic drugmakers paid to settle first Zantac case before trial, Bloomberg says 08/11/22 GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports HLN Haleon $8.09 / +0.09 (+1.13%) 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/11/22 What You Missed On Wall Street This Morning

Events

Earnings calls, analyst events, roadshows and more

HA
Today at 16:30

Hawaiian Holdings - HA Conference Calls
CENT
Today at 16:30

Central Garden & Pet - CENT Conference Calls
SYK
Today at 16:30

Stryker - SYK Conference Calls
CENTA
Today at 16:30

Central Garden & Pet - CENTA Conference Calls
CP
Today at 16:30

Canadian Pacific - CP Conference Calls
ATGN
Today at 16:30

AltiGen Communications Inc - ATGN Conference Calls
AMGN
Today at 16:30

Amgen - AMGN Conference Calls
WDC
Today at 16:30

Western Digital - WDC Conference Calls
MRCY
Today at 17:00

Mercury Systems - MRCY Conference Calls
JNPR
Today at 17:00

Juniper - JNPR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ITGR X ITGR Integer Secondary Managers: BofA, Citi & Wells Fargo, Piper Sandler, KeyBanc, Fifth Third, Grupo Santander, SVB Securities, Capital One, Regions Securities, M & T Bank $70.74 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SODR X SODR Sondors IPO Managers: DA Davidson & Lake Street $8.00 - 10.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ASST X ASST Asset Entities IPO Managers: Boustead $5.00 1.5M Shares
Fri	No deals

View All Syndicate Announcements »

Acacia Research appoints Martin McNulty as COO, Wesley Golby as CIO

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access